+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

Synovial Sarcoma - Pipeline Insight, 2024 - Product Thumbnail Image

Synovial Sarcoma - Pipeline Insight, 2024

  • Clinical Trials
  • November 2024
  • 80 Pages
  • Global
From
Familial adenomatous polyposis - Pipeline Insight, 2024 - Product Thumbnail Image

Familial adenomatous polyposis - Pipeline Insight, 2024

  • Clinical Trials
  • November 2024
  • 60 Pages
  • Global
From
Cutaneous T-cell lymphoma - Pipeline Insight, 2024 - Product Thumbnail Image

Cutaneous T-cell lymphoma - Pipeline Insight, 2024

  • Clinical Trials
  • November 2024
  • 80 Pages
  • Global
From
Metastatic Triple-Negative Breast Cancer (mTNBC)- Pipeline Insight, 2024 - Product Thumbnail Image

Metastatic Triple-Negative Breast Cancer (mTNBC)- Pipeline Insight, 2024

  • Clinical Trials
  • November 2024
  • 60 Pages
  • Global
From
Muscle Invasive Bladder cancer- Pipeline Insight, 2024 - Product Thumbnail Image

Muscle Invasive Bladder cancer- Pipeline Insight, 2024

  • Clinical Trials
  • August 2024
  • 60 Pages
  • Global
From
Intrahepatic Cholangiocarcinoma (ICC)- Pipeline Insight, 2024 - Product Thumbnail Image

Intrahepatic Cholangiocarcinoma (ICC)- Pipeline Insight, 2024

  • Clinical Trials
  • August 2024
  • 80 Pages
  • Global
From
Pheochromocytoma- Pipeline Insight, 2024 - Product Thumbnail Image

Pheochromocytoma- Pipeline Insight, 2024

  • Drug Pipelines
  • August 2024
  • 60 Pages
  • Global
From
Leptomeningeal Metastases - Pipeline Insight, 2024 - Product Thumbnail Image

Leptomeningeal Metastases - Pipeline Insight, 2024

  • Drug Pipelines
  • August 2024
  • 60 Pages
  • Global
From
Thyroid Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Thyroid Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • August 2024
  • 180 Pages
  • Global
From
HER2 Positive Breast Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

HER2 Positive Breast Cancer - Pipeline Insight, 2024

  • Drug Pipelines
  • August 2024
  • 180 Pages
  • Global
From
B-Cell Non-Hodgkin Lymphoma - Pipeline Insight, 2024 - Product Thumbnail Image

B-Cell Non-Hodgkin Lymphoma - Pipeline Insight, 2024

  • Clinical Trials
  • July 2024
  • 240 Pages
  • Global
From
Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Insight, 2024 - Product Thumbnail Image

Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Insight, 2024

  • Clinical Trials
  • July 2024
  • 180 Pages
  • Global
From
Untreated Metastatic or Unresectable Melanoma - Pipeline Insight, 2024 - Product Thumbnail Image

Untreated Metastatic or Unresectable Melanoma - Pipeline Insight, 2024

  • Drug Pipelines
  • July 2024
  • 80 Pages
  • Global
From
IPSC derived NK cells - Pipeline Insight, 2024 - Product Thumbnail Image

IPSC derived NK cells - Pipeline Insight, 2024

  • Drug Pipelines
  • July 2024
  • 60 Pages
  • Global
From
Biliary Tumor - Pipeline Insight, 2024 - Product Thumbnail Image

Biliary Tumor - Pipeline Insight, 2024

  • Clinical Trials
  • July 2024
  • 180 Pages
  • Global
From
From
From
Chemotherapy Induced Peripheral Neuropathy - Pipeline Insight, 2024 - Product Thumbnail Image

Chemotherapy Induced Peripheral Neuropathy - Pipeline Insight, 2024

  • Clinical Trials
  • June 2024
  • 60 Pages
  • Global
From
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more